Yifeng Pharmacy

603939

22.471.49% ( +0.33 )

Delay Closed: Jul 28, 15:00:00

Q1 2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Yifeng Pharmacy(603939) predict that the Revenue is 6.085 B (+1.26%), Miss estimate;the EBIT is 727.66 M (+11.86%), Beat estimate;the EPS is 0.4 (+11.11%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

6.09B1.26%

6.40B6.59%

-0.32B5.33%

EBITExceed expectations

0.73B11.86%

0.70B8.36%

+0.02B3.50%

EPSExceed expectations

0.411.11%

0.399210.88%

+0.00080.23%

Revenue

ActualEstimateUnit: CNY

EBIT

ActualEstimateUnit: CNY

Net income

ActualEstimateUnit: CNY

EPS

ActualEstimateUnit: CNY